Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia

2017 Taiwan lipid guidelines for high risk patients

(2017) Yi-Heng Li et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms

(2016) Kathryn Brigham Egan   UROLOGIC CLINICS OF NORTH AMERICA

Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms

(2016) Jay H. Fowke et al.   PLoS One

Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database

(2015) Cheng-Yang Hsieh et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective

(2015) Hala H. Mosli et al.   Scientific Reports

Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK

(2014) Mark Speakman et al.   BJU INTERNATIONAL

Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions

(2014) Giovanni Corona et al.   International Journal of Endocrinology

Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases

(2014) Hitoshi Ishiguro et al.   Biomed Research International

Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials

(2013) Arman Kahokehr et al.   BJU INTERNATIONAL

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

(2012) Linda Vignozzi et al.   PROSTATE

The Impact of Dietary Changes and Dietary Supplements on Lipid Profile

(2011) Jingbo Huang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Cholesterol and benign prostate disease

(2011) Michael R. Freeman et al.   DIFFERENTIATION

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation

(2009) G. Penna et al.   JOURNAL OF IMMUNOLOGY

Increased cell proliferation and contractility of prostate in insulin resistant rats: Linking hyperinsulinemia with benign prostate hyperplasia

(2009) A. Vikram et al.   PROSTATE

Etiology, Epidemiology, and Natural History

(2009) Wade Bushman   UROLOGIC CLINICS OF NORTH AMERICA

Diabetes and benign prostatic hyperplasia: Emerging clinical connections

(2009) Aruna V. Sarma et al.   Current Urology Reports

Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial

(2008) A. R. Kristal et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management

(2008) M. Emberton et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men

(2007) J. Kellogg Parsons et al.   BJU INTERNATIONAL

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

(2007) J. Curtis Nickel et al.   EUROPEAN UROLOGY